Early endothelin-A receptor blockade decreases blood pressure and ameliorates end-organ damage in homozygous Ren-2 rats.

Hypertension

Volumn 46, Issue 4, 2005, Pages 969-974

  Vanêcková, Ivana ^a   Kramer, Herbert J ^a   Bäcker, Angela ^a   Vernerová, Zdena ^a   Opocensky, Martin ^a   Cervenka, Ludêk ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ATRASENTAN; BOSENTAN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; PYRROLIDINE DERIVATIVE; REN2 PROTEIN, MOUSE; RENIN; SULFONAMIDE;

ANIMAL; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CARDIOMEGALY; DRUG ANTAGONISM; FOCAL GLOMERULOSCLEROSIS; HEART MUSCLE; HEART VENTRICLE; HYPERTENSION; KIDNEY; MALE; METABOLISM; ORGAN SIZE; OSMOLARITY; PATHOLOGY; PATHOPHYSIOLOGY; PROTEINURIA; RAT; SALT INTAKE; SPRAGUE DAWLEY RAT; SURVIVAL; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOOD PRESSURE; BODY WEIGHT; CARDIOMEGALY; ENDOTHELIN-1; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HEART VENTRICLES; HYPERTENSION; KIDNEY; MALE; MYOCARDIUM; ORGAN SIZE; OSMOLAR CONCENTRATION; PROTEINURIA; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RENIN; SODIUM CHLORIDE, DIETARY; SULFONAMIDES; SURVIVAL ANALYSIS;

EID: 33644638520     PISSN: None     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.0000173426.06832.b5     Document Type: Article

References (0)